Michael E Farkouh Selected Research

Fidexaban

3/2007

Potent arterial antithrombotic effect of direct factor-Xa inhibition with ZK-807834 administered to coronary artery disease patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael E Farkouh Research Topics

Disease

45	Myocardial Infarction 10/2022 - 08/2004
29	Coronary Artery Disease (Coronary Atherosclerosis) 06/2022 - 03/2007
24	Stroke (Strokes) 01/2022 - 07/2008
23	Coronary Disease (Coronary Heart Disease) 01/2022 - 07/2008
22	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 12/2002
16	Diabetes Mellitus 01/2022 - 10/2008
16	Heart Failure 12/2021 - 08/2008
12	Hemorrhage 01/2022 - 11/2004
12	Acute Coronary Syndrome 01/2021 - 01/2006
10	Inflammation (Inflammations) 06/2015 - 01/2008
9	Thrombosis (Thrombus) 06/2022 - 03/2007
9	Type 2 Diabetes Mellitus (MODY) 12/2021 - 07/2010
7	Myocardial Ischemia (Ischemic Heart Diseases) 03/2022 - 03/2013
7	Chronic Renal Insufficiency 01/2022 - 07/2008
7	Hypertension (High Blood Pressure) 01/2022 - 08/2008
6	COVID-19 06/2022 - 10/2020
6	Unstable Angina 12/2020 - 11/2004
6	Atherosclerosis 10/2018 - 02/2007
6	Atherosclerotic Plaque (Atheroma) 06/2015 - 11/2004
5	Ischemia 01/2022 - 01/2019
4	Arthritis (Polyarthritis) 01/2022 - 08/2004
4	Critical Illness (Critically Ill) 01/2022 - 08/2021
4	Chest Pain (Chest Pains) 05/2020 - 06/2012
3	Dyslipidemias (Dyslipidemia) 04/2022 - 02/2016
3	ST Elevation Myocardial Infarction 06/2013 - 12/2011
2	Human Influenza (Influenza) 01/2021 - 01/2018
2	Weight Loss (Weight Reduction) 01/2020 - 06/2014
2	Peripheral Arterial Disease 01/2020 - 01/2009
2	Fibrosis (Cirrhosis) 01/2019 - 09/2008
2	Hypotension (Low Blood Pressure) 01/2018 - 04/2013
2	Pathologic Constriction (Stenosis) 01/2018 - 01/2018
2	Neoplasms (Cancer) 05/2017 - 06/2013
2	Chronic Pain 01/2016 - 05/2009
2	Arteritis 06/2015 - 03/2009
2	Renal Insufficiency (Renal Failure) 05/2015 - 01/2009
2	Osteoarthritis 11/2013 - 08/2004
2	Coronary Occlusion 06/2012 - 12/2010
2	Infarction (Infarctions) 12/2011 - 05/2007
2	Cardiogenic Shock 08/2011 - 05/2007
2	Necrosis 04/2011 - 02/2011
2	Hypercholesterolemia 04/2010 - 11/2007
2	Edema (Dropsy) 08/2008 - 02/2008

Drug/Important Bio-Agent (IBA)

26	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 12/2002
8	omega-Chloroacetophenone (Mace)IBA 01/2022 - 12/2016
8	LDL CholesterolIBA 10/2021 - 07/2012
8	TroponinIBA 01/2021 - 01/2006
7	Pharmaceutical PreparationsIBA 01/2021 - 05/2005
7	Biomarkers (Surrogate Marker)IBA 10/2018 - 03/2009
7	LipidsIBA 10/2018 - 04/2010
6	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 03/2007
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2022 - 08/2004
5	oxidized low density lipoproteinIBA 10/2021 - 08/2014
5	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 05/2011
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2016 - 02/2008
4	MetalsIBA 12/2020 - 01/2009
3	Clopidogrel (Plavix)FDA Link 12/2021 - 03/2007
3	Ezetimibe (Zetia)FDA Link 10/2021 - 10/2015
3	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021 - 10/2013
3	Triglycerides (Triacylglycerol)IBA 01/2020 - 05/2011
3	HDL CholesterolIBA 01/2019 - 05/2011
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2018 - 06/2015
3	Atorvastatin (Lipitor)FDA Link 06/2015 - 07/2013
3	dalcetrapibIBA 10/2013 - 08/2011
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2013 - 08/2004
3	Naproxen (Naprosyn)FDA LinkGeneric 08/2008 - 08/2004
3	lumiracoxib (prexige)IBA 08/2008 - 08/2004
3	Ibuprofen (Motrin)FDA LinkGeneric 08/2008 - 08/2004
2	CholesterolIBA 04/2022 - 11/2007
2	AnticoagulantsIBA 01/2022 - 01/2021
2	Everolimus FDA Link 01/2022 - 01/2018
2	Prasugrel Hydrochloride FDA Link 12/2021 - 10/2008
2	Cytochrome P-450 CYP2C19IBA 12/2021 - 01/2020
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 03/2020
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 03/2020
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 03/2020
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 04/2013
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020 - 06/2017
2	Fibrinogen (Factor I)FDA Link 11/2019 - 01/2018
2	CollagenIBA 01/2019 - 09/2008
2	LDL Lipoproteins (beta Lipoproteins)IBA 10/2018 - 05/2015
2	CreatinineIBA 02/2016 - 08/2013
2	C-Reactive ProteinIBA 06/2015 - 05/2011
2	Warfarin (Coumadin)FDA LinkGeneric 05/2015 - 06/2013
2	Insulin (Novolin)FDA Link 09/2014 - 02/2007
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2014 - 02/2014
2	Cholesterol Ester Transfer ProteinsIBA 10/2013 - 08/2011
2	Cystatin CIBA 02/2013 - 07/2008
2	Abciximab (ReoPro)FDA Link 10/2007 - 03/2007

Therapy/Procedure

40	Therapeutics 06/2022 - 12/2002
32	Percutaneous Coronary Intervention 03/2022 - 06/2009
27	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 06/2022 - 02/2013
14	Stents 01/2022 - 11/2004
7	Drug-Eluting Stents 01/2019 - 01/2009
5	Myocardial Revascularization 07/2021 - 12/2011
3	Secondary Prevention 12/2018 - 04/2013
2	Critical Care (Surgical Intensive Care) 08/2021 - 01/2021
2	Patient Readmission 01/2020 - 12/2018
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 11/2019 - 01/2018
2	Drug Therapy (Chemotherapy) 12/2018 - 12/2011
2	Renal Dialysis (Hemodialysis) 10/2014 - 11/2005